NCT04937777: EMN 23 - Study on the Management & Outcome of Systemic AL Amyloidosis in Europe
Updated: Feb 10
EMN 23
NCT04937777: A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe
NCT04937777: A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe
This is a retrospective, observational, multicenter study to collect Real-World Evidence (RWE) data on systemic AL-AMY patients in Europe. Data from paper/electronic medical records and/or electronic databases from key reference centers in Europe will be used. Data will either be entered by the site staff in the electronic Case Report Form (eCRF) or, where feasible, transferred directly, always in accordance to local regulations.
Sponsor
ClinicalTrials.gov Identifier: NCT04937777
Official Title: A Retrospective Observational Multicenter Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe
First Posted : June 24, 2021
Click here to see details on ClinicalTrials.gov
Locations
Europe
United Kingdom
Austria
Czechia
France
Germany
Greece
Italy
Netherlands
Portugal
Spain